Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. Over the next few months, the illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained.
Severe Acute Respiratory Syndrome

SARS or Severe Acute Respiratory Syndrome is a viral respiratory illness caused by a coronavirus - the SARS associated coronavirus (SARS-CoV) - which can be life-threatening.

Read More

Overview

Latest Severe Acute Respiratory Syndrome News and Research

Study on the lung-function trajectories in COVID-19 patients

Study on the lung-function trajectories in COVID-19 patients

Bioactive compounds derived from Ganoderma lucidum exhibit anti-SARS-CoV-2 activity

Bioactive compounds derived from Ganoderma lucidum exhibit anti-SARS-CoV-2 activity

Pluripotent bat stem cells as a model to study novel viruses

Pluripotent bat stem cells as a model to study novel viruses

A novel method to identify spike stabilizing mutations for COVID-19 vaccine development

A novel method to identify spike stabilizing mutations for COVID-19 vaccine development

Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance

Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance

What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants?

What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants?

How a major COVID-19 outbreak occurred in a naïve and vaccinated population in Taiwan with a limited number of entry events

How a major COVID-19 outbreak occurred in a naïve and vaccinated population in Taiwan with a limited number of entry events

Study examines the incidence of severe COVID-19 in fully vaccinated and boosted high-risk populations

Study examines the incidence of severe COVID-19 in fully vaccinated and boosted high-risk populations

Study suggests B-cell responses to booster vaccines are impeded by recent SARS-CoV-2 infection

Study suggests B-cell responses to booster vaccines are impeded by recent SARS-CoV-2 infection

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Smartphone-based assessment of long COVID symptomatology and risk factors

Smartphone-based assessment of long COVID symptomatology and risk factors

Significant humoral immune evasion contributes to the emergence and rapid spread of Arg346-mutated BA.4 and BA.5 sublineages

Significant humoral immune evasion contributes to the emergence and rapid spread of Arg346-mutated BA.4 and BA.5 sublineages

Study aims to understand how SARS-CoV-2 affects the brain long-term

Study aims to understand how SARS-CoV-2 affects the brain long-term

What is the role of N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 spike maturation?

What is the role of N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 spike maturation?

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

Can the gut be an alternative route for SARS-CoV-2 entry?

Can the gut be an alternative route for SARS-CoV-2 entry?

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19